Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-30

Clinical Trial Update: Programed Intermittent Epidural Bolus Interval 90 (EI90) of 10 ml, 0.0625% Bupivacaine Plus 2 μg/mL Fentanyl [NA]

View source ↗

Summary

Clinical trial update on an intermittent epidural bolus regimen using 10 mL of 0.0625% bupivacaine with 2 μg/mL fentanyl for labor pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • FENTANYL (FENTANYL)

Snippet

Sponsor: Menoufia University | Conditions: Labour Pain | NA | Status: COMPLETED